These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2784 related articles for article (PubMed ID: 8129040)

  • 21. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors.
    Guha A; Lau N; Huvar I; Gutmann D; Provias J; Pawson T; Boss G
    Oncogene; 1996 Feb; 12(3):507-13. PubMed ID: 8637706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplacental induction of peripheral nervous tumor in the Syrian golden hamster by N-nitroso-N-ethylurea. A new animal model for von Recklinghausen's neurofibromatosis.
    Nakamura T; Hara M; Kasuga T
    Am J Pathol; 1989 Aug; 135(2):251-9. PubMed ID: 2551169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
    Su W; Xing R; Guha A; Gutmann DH; Sherman LS
    Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurofibromas in NF1: Schwann cell origin and role of tumor environment.
    Zhu Y; Ghosh P; Charnay P; Burns DK; Parada LF
    Science; 2002 May; 296(5569):920-2. PubMed ID: 11988578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the tyrosinase gene promoter by neurofibromin.
    Suzuki H; Takahashi K; Yasumoto K; Shibahara S
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1984-91. PubMed ID: 7811291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced neurofibromin content but normal GAP activity in a patient with neurofibromatosis type 1 caused by a five base pair duplication in exon 12b of the NF1 gene.
    Böddrich A; Griesser J; Horn D; Kaufmann D; Krone W; Nürnberg P
    Biochem Biophys Res Commun; 1995 Sep; 214(3):895-904. PubMed ID: 7575561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
    Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA
    Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation.
    Nishi T; Lee PS; Oka K; Levin VA; Tanase S; Morino Y; Saya H
    Oncogene; 1991 Sep; 6(9):1555-9. PubMed ID: 1923522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.
    Zheng H; Chang L; Patel N; Yang J; Lowe L; Burns DK; Zhu Y
    Cancer Cell; 2008 Feb; 13(2):117-28. PubMed ID: 18242512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
    Wu M; Wallace MR; Muir D
    J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.
    Gutmann DH; Giordano MJ; Mahadeo DK; Lau N; Silbergeld D; Guha A
    Oncogene; 1996 May; 12(10):2121-7. PubMed ID: 8668337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
    Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
    Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plexiform-like neurofibromas develop in the mouse by intraneural xenograft of an NF1 tumor-derived Schwann cell line.
    Perrin GQ; Fishbein L; Thomson SA; Thomas SL; Stephens K; Garbern JY; DeVries GH; Yachnis AT; Wallace MR; Muir D
    J Neurosci Res; 2007 May; 85(6):1347-57. PubMed ID: 17335073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone.
    Overdiek A; Winner U; Mayatepek E; Rosenbaum T
    Pediatr Res; 2008 Jul; 64(1):40-3. PubMed ID: 18360307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis.
    Peltonen J; Jaakkola S; Lebwohl M; Renvall S; Risteli L; Virtanen I; Uitto J
    Lab Invest; 1988 Dec; 59(6):760-71. PubMed ID: 2462129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin.
    Roth TM; Ramamurthy P; Muir D; Wallace MR; Zhu Y; Chang L; Barald KF
    Dev Dyn; 2008 Feb; 237(2):513-24. PubMed ID: 18213578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen's disease.
    Kimura N; Watanabe T; Fukase M; Wakita A; Noshiro T; Kimura I
    Mod Pathol; 2002 Mar; 15(3):183-8. PubMed ID: 11904334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines.
    Andersen LB; Fountain JW; Gutmann DH; Tarlé SA; Glover TW; Dracopoli NC; Housman DE; Collins FS
    Nat Genet; 1993 Feb; 3(2):118-21. PubMed ID: 8499944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.
    Luscan A; Shackleford G; Masliah-Planchon J; Laurendeau I; Ortonne N; Varin J; Lallemand F; Leroy K; Dumaine V; Hivelin M; Borderie D; De Raedt T; Valeyrie-Allanore L; Larousserie F; Terris B; Lantieri L; Vidaud M; Vidaud D; Wolkenstein P; Parfait B; Bièche I; Massaad C; Pasmant E
    Clin Cancer Res; 2014 Jan; 20(2):358-71. PubMed ID: 24218515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
    Weiss B; Bollag G; Shannon K
    Am J Med Genet; 1999 Mar; 89(1):14-22. PubMed ID: 10469432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 140.